Lidia Gil
Impact in
- Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management
- Hematology top 2%
- Hematopoietic Stem Cell Transplantation
Papers in
- Hematology 52
- Hematopoietic Stem Cell Transplantation 16
- Acute Myeloid Leukemia Research 11
- Multiple Myeloma Research and Treatments 10
- Chronic Myeloid Leukemia Treatments 10
- Oncology 47
- Neutropenia and Cancer Infections 12
- Viral-associated cancers and disorders 12
- Co-authors
- Mieczysław Komarnicki (35 shared papers)Jan Styczyński (25 shared papers)Joanna Rupa‐Matysek (31 shared papers)Per Ljungman (2 shared papers)Hermann Einsele (1 shared paper)Maciej Kaźmierczak (7 shared papers)Dominik Dytfeld (22 shared papers)Katarzyna Brzeźniakiewicz‐Janus (11 shared papers)
- Journals
- Bone Marrow Transplantation (7 papers)Annals of Hematology (6 papers)Medical Oncology (5 papers)Journal of Clinical Medicine (4 papers)Disease Markers (3 papers)
- Partner nations
- PolandSpainUnited States
In The Last Decade
Lidia Gil
120 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 94
- Internal Medicine 129
- Hematology 369
- Genetics 238
- Oncology 379
- Pathology and Forensic Medicine 146
Countries citing papers authored by Lidia Gil
This map shows the geographic impact of Lidia Gil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lidia Gil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lidia Gil more than expected).
Fields of papers citing papers by Lidia Gil
This network shows the impact of papers produced by Lidia Gil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lidia Gil. The network helps show where Lidia Gil may publish in the future.
Co-authors
The 25 scholars most cited alongside Lidia Gil, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 139 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 141 | |
| 2 | 2009 | 75 | |
| 3 | 2007 | 64 | |
| 4 | 2020 | 63 | |
| 5 | 2014 | 59 | |
| 6 | 2018 | 42 | |
| 7 | 2017 | 38 | |
| 8 | 2008 | 37 | |
| 9 | 2008 | 32 | |
| 10 | 2018 | 28 | |
| 11 | 2019 | 25 | |
| 12 | 2018 | 22 | |
| 13 | 2019 | 21 | |
| 14 | 2014 | 20 | |
| 15 | 2016 | 20 | |
| 16 | Activity of bortezomib in adult de novo and relapsed acute myeloid leukemia. | 2008 | 20 |
| 17 | 2023 | 19 | |
| 18 | 2012 | 18 | |
| 19 | 2008 | 16 | |
| 20 | 2019 | 15 |
About Lidia Gil
Lidia Gil is a scholar working on Hematology, Oncology, Epidemiology, Genetics and Pathology and Forensic Medicine, having authored 139 papers that have together received 1.2k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (16 papers), Lymphoma Diagnosis and Treatment (14 papers), Neutropenia and Cancer Infections (12 papers), Viral-associated cancers and disorders (12 papers), Chronic Lymphocytic Leukemia Research (12 papers), Acute Myeloid Leukemia Research (11 papers), Multiple Myeloma Research and Treatments (10 papers) and Chronic Myeloid Leukemia Treatments (10 papers). The work is most often cited by research in Internal Medicine (129 citations), Hematology (369 citations), Genetics (238 citations), Oncology (379 citations) and Pathology and Forensic Medicine (146 citations). Lidia Gil has collaborated with scholars based in Poland, Spain and United States. Frequent co-authors include Mieczysław Komarnicki, Jan Styczyński, Joanna Rupa‐Matysek, Per Ljungman, Hermann Einsele, Maciej Kaźmierczak, Dominik Dytfeld, Katarzyna Brzeźniakiewicz‐Janus, Elżbieta Nowakowska and Anna Olewicz‐Gawlik. Their work appears in journals such as Bone Marrow Transplantation, Annals of Hematology, Medical Oncology, Journal of Clinical Medicine and Disease Markers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.